Cover Image

Hyperbilirubinemia in atazanavir-treated human immunodeficiency virus-infected patients: the impact of the UGT1A1*28 allele

Anushka Naidoo,1 Kogieleum Naidoo,1,2 Veron Ramsuran,3 Millidhashni Reddy,1 Nesri Padayatchi1,2 1Centre for the AIDS Programme of Research in South Africa, 2MRC-CAPRISA HIV-TB Pathogenesis and Treatment Research Unit, Doris Duke Medical Research Institute, 3School of Laboratory Medicine and Medical...

Full description

Saved in:

Bibliographic Details
Main Authors:	Naidoo A (Author), Naidoo K (Author), Ramsuran V (Author), Reddy M (Author), Padayatchi N (Author)
Format:	Book
Published:	Dove Medical Press, 2017-08-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Hyperbilirubinemia in atazanavir treated HIV-infected patients: the impact of the UGT1A1*28 allele
by: Panagopoulos P, et al.
Published: (2017)

Profiling of UGT1A1*6, UGT1A1*60, UGT1A1*93, and UGT1A1*28 Polymorphisms in Indonesian Neonates With Hyperbilirubinemia Using Multiplex PCR Sequencing
by: Radhian Amandito, et al.
Published: (2019)

Commentary: Profiling of UGT1A1*6, UGT1A1*60, UGT1A1*93, and UGT1A1*28 Polymorphisms in Indonesian Neonates With Hyperbilirubinemia Using Multiplex PCR Sequencing
by: Mohammad Reza Heydari, et al.
Published: (2020)

211 G to A variation of UGT1A1 and severe neonatal hyperbilirubinemia
by: Yu-Jung Lin, et al.
Published: (2018)

Clinical Significance of UGT1A1 Genetic Analysis in Chinese Neonates with Severe Hyperbilirubinemia
by: Hui Yang, et al.
Published: (2016)

Pharmacogenetic Associations Between Atazanavir/UGT1A1*28 and Efavirenz/rs3745274 (CYP2B6) Account for Specific Adverse Reactions in Chilean Patients Undergoing Antiretroviral Therapy
by: Daniela Poblete, et al.
Published: (2021)

Genotyping of <i>UGT1A1*</i>80 as an Alternative to <i>UGT1A1*</i>28 Genotyping in Spain
by: Adrián Bravo-Gómez, et al.
Published: (2022)

The role of UGT1A1 (c.-3279 T > G) gene polymorphisms in neonatal hyperbilirubinemia susceptibility
by: Zijin Li, et al.
Published: (2020)

Associations between UGT1A1 and SLCO1B1 polymorphisms and susceptibility to neonatal hyperbilirubinemia in Thai population
by: Chalirmporn Atasilp, et al.
Published: (2022)

Investigating Whether Screening or Testing for the Variation Status of UGT 1A1 Gene is Helpful in Managing Neonatal Hyperbilirubinemia
by: Yao-Jong Yang
Published: (2020)

A novel UGT1A1 gene mutation causing severe unconjugated hyperbilirubinemia: a case report
by: Xiaoxia Shi, et al.
Published: (2019)

Lived experiences of human immunodeficiency virus and hypertension in the Eastern Cape, South Africa
by: Lwandile Tokwe, et al.
Published: (2020)

Gilbert or Crigler-Najjar syndrome? Neonatal severe unconjugated hyperbilirubinemia with P364L UGT1A1 homozygosity
by: Laura Cozzi, et al.
Published: (2022)

UGT1A1 mutation association with increased bilirubin levels and severity of unconjugated hyperbilirubinemia in ABO incompatible newborns of China
by: Hui Yang, et al.
Published: (2021)

Study of atazanavir-induced hyperbilirubinemia among HIV patients on second-line anti-retroviral therapy
by: K Ravi, et al.
Published: (2020)

Hypertension among human immunodeficiency virus infected patients on treatment at Parirenyatwa Hospital: A descriptive study
by: Rumbidzai Chireshe, et al.
Published: (2019)

Developing and evaluating a predictive model for neonatal hyperbilirubinemia based on UGT1A1 gene polymorphism and clinical risk factors
by: Zhaoyang Cui, et al.
Published: (2024)

Co-inheritance of G6PD deficiency and 211 G to a variation of UGT1A1 in neonates with hyperbilirubinemia in eastern Guangdong
by: Jia-Xin Xu, et al.
Published: (2021)

Association of UGT1A1*6, UGT1A1*28, or ABCC2 c.3972C>T genetic polymorphisms with irinotecan‐induced toxicity in Asian cancer patients: Meta‐analysis
by: Chalirmporn Atasilp, et al.
Published: (2022)

Relationship between UGT1A1*6/*28 polymorphisms and severe toxicities in Chinese patients with pancreatic or biliary tract cancer treated with irinotecan-containing regimens
by: Yang C, et al.
Published: (2015)

Influence of UGT1A1 *6/*28 Polymorphisms on Irinotecan-Related Toxicity and Survival in Pediatric Patients with Relapsed/Refractory Solid Tumors Treated with the VIT Regimen
by: Zhu X, et al.
Published: (2021)

Cost-Effectiveness of UGT1A1*28 Genotyping in Preventing Severe Neutropenia Following FOLFIRI Therapy in Colorectal Cancer.
by: Solen Pichereau, et al.
Published: (2011)

Eradication of Human Immunodeficiency Virus Type-1 (HIV-1)-Infected Cells
by: Nejat Düzgüneş, et al.
Published: (2019)

CORRIGENDUM: Quantitative Systems Pharmacology Model of hUGT1A1‐modRNA Encoding for the UGT1A1 Enzyme to Treat Crigler‐Najjar Syndrome Type 1
by: J.F. Apgar, et al.
Published: (2020)

Associations between UGT1A1, SLCO1B1, SLCO1B3, BLVRA and HMOX1 polymorphisms and susceptibility to neonatal severe hyperbilirubinemia in Chinese Han population
by: Juan Fan, et al.
Published: (2024)

Intracranial pressure management in patients with human immunodeficiency virus-associated cryptococcal meningitis in a resource-constrained setting
by: Philasande Mkoko, et al.
Published: (2020)

Antenatal Atazanavir: A Retrospective Analysis of Pregnancies Exposed to Atazanavir
by: Miriam Samuel, et al.
Published: (2014)

UGT1A1 rs4148323 A Allele is Associated With Increased 2-Hydroxy Atorvastatin Formation and Higher Death Risk in Chinese Patients With Coronary Artery Disease
by: He-Ping Lei, et al.
Published: (2021)

Role of atazanavir in the treatment of HIV infection
by: Pablo Rivas, et al.
Published: (2008)

Human Immunodeficiency Virus Infection and Pregnancy
by: Richard H. Schwarz
Published: (1994)

Human Immunodeficiency Virus Infection And Tuberculosis
by: Ghosal A G, et al.
Published: (2002)

Bilirubin Links <i>HO-1</i> and <i>UGT1A1*28</i> Gene Polymorphisms to Predict Cardiovascular Outcome in Patients Receiving Maintenance Hemodialysis
by: Yang Ho, et al.
Published: (2021)

Targeting Human Immunodeficiency Virus Type 1 Assembly, Maturation and Budding
by: Johanna Wapling, et al.
Published: (2007)

Predictors of Non-Uptake of Human Immunodeficiency Virus Testing by Tuberculosis Public Primary Patients in Three Districts, South Africa
by: G Matseke, et al.
Published: (2012)

Predictors of Non-Uptake of Human Immunodeficiency Virus Testing by Tuberculosis Public Primary Patients in Three Districts, South Africa
by: K Peltzer, et al.
Published: (2012)

Pregnancy-Related Hormones Increase UGT1A1-Mediated Labetalol Metabolism in Human Hepatocytes
by: Raju Khatri, et al.
Published: (2021)

A Case of Disseminated Cutaneous Herpes Simplex Virus-1 as the First Manifestation of Human Immunodeficiency Virus Infection
by: Parker Brown BS, et al.
Published: (2021)

UGT1A1 polymorphisms in cancer: impact on irinotecan treatment
by: Takano M, et al.
Published: (2017)

UGT1A1 gene polymorphisms and jaundice in Indonesian neonates
by: Rinawati Rohsiswatmo, et al.
Published: (2019)

Blood levels of some toxic metals in Human Immunodeficiency Virus (HIV) Type 1- infection
by: Emokpae Mathias Abiodun, et al.
Published: (2018)